Lifecode
Lifecode Health is a specialized clinical laboratory and research branch of MedGenome Inc. focused on providing patient-specific molecular information for cancer care using next-generation sequencing (NGS) and advanced bioinformatics. Their flagship product, the Lifecode Pan Cancer Somatic Panel, offers concise, accurate, and actionable genomic data to help physicians make informed treatment decisions. The company combines expertise in data science, computational biology, machine learning, and pathology to interpret complex genomic and therapeutic data. Lifecode is CLIA certified and CAP accredited, funded by Sequoia Capital and The Mayo Clinic, blending software innovation with clinical laboratory excellence. Their initial focus is oncology, addressing the needs of millions of cancer patients in the U.S. by enabling personalized medicine through molecular tumor profiling. Lifecode collaborates with healthcare software developers to enhance precision and is actively growing its team to advance genomically driven cancer care.
Lifecode
Lifecode Health is a specialized clinical laboratory and research branch of MedGenome Inc. focused on providing patient-specific molecular information for cancer care using next-generation sequencing (NGS) and advanced bioinformatics. Their flagship product, the Lifecode Pan Cancer Somatic Panel, offers concise, accurate, and actionable genomic data to help physicians make informed treatment decisions. The company combines expertise in data science, computational biology, machine learning, and pathology to interpret complex genomic and therapeutic data. Lifecode is CLIA certified and CAP accredited, funded by Sequoia Capital and The Mayo Clinic, blending software innovation with clinical laboratory excellence. Their initial focus is oncology, addressing the needs of millions of cancer patients in the U.S. by enabling personalized medicine through molecular tumor profiling. Lifecode collaborates with healthcare software developers to enhance precision and is actively growing its team to advance genomically driven cancer care.